Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Cryoprevention of oral mucositis

Reference number
Coordinator BrainCool AB (publ)
Funding from Vinnova SEK 500 000
Project duration November 2016 - November 2018
Status Completed

Purpose and goal

The primary aim is to study patients with myeloma or lymphoma undergoing autologous SCT, to evaluate whether cooling with Cooral compared with ice cubes/crushed ice or ice pop succeeds in reducing the degree of OM according to the Oral Mucositis Assessment Scale, OMAS total.

Expected results and effects

The results are expected following inclusion of a total of 180 patients

Planned approach and implementation

All measurements, with the exception of the patient’s subjective assessment of the cooling method, will be registered beginning at admission and will continue until discharge or until day +28. Cytostatic infusion generally starts on the day after admission. Grading of OM according to OMAS and WHO is done three times a week. Assessment of the two cooling methods is performed after completion of ice/Cooral cooling in conjunction with cytostatic infusion. Body temperature is registered in the oral cavity in accordance with the department’s routines.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 January 2019

Reference number 2016-04171

Page statistics